TMI-358

· Talima Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TMI-358, covering 2011-01-17 to 2011-01-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis [Phase 2]